Back to People Listing
Affiliate Faculty

Georgia Tomaras

Professor (with tenure), Department of Surgery
Professor, Department of Immunology
Professor, Department of Molecular Genetics and Microbiology
School of Medicine
(919) 681-5598
Georgia Tomaras


Dr. Tomaras' overall research program is to understand the cellular and humoral immune response to HIV-1 infection and vaccination that are involved in protection from HIV-1. The research in the Tomaras laboratory centers around three main projects involving 1) antiviral CD8 T cell responses in HIV-1 infection and post vaccination, 2) mucosal and systemic antibody responses to infection and vaccination in both non-human primates and humans and 3) the ontogeny of neutralizing antibodies in HIV-1 infection. Her laboratory is also within the Duke Human Vaccine Institute.



Recent Publications

Asbach, B, Kibler, KV, Köstler, J, Perdiguero, B, Yates, NL, Stanfield-Oakley, S, Tomaras, GD, Kao, S-F, Foulds, KE, Roederer, M, Seaman, MS, Montefiori, DC, Parks, R, Ferrari, G, Forthal, DN, Phogat, S, Tartaglia, J, Barnett, SW, Self, SG, Gottardo, R, Cristillo, AD, Weiss, DE, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Jacobs, BL, Pantaleo, G, & Wagner, R. (2018, November 14). Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost.
Kibler, KV, Asbach, B, Perdiguero, B, García-Arriaza, J, Yates, NL, Parks, R, Stanfield-Oakley, S, Ferrari, G, Montefiori, DC, Tomaras, GD, Roederer, M, Foulds, KE, Forthal, DN, Seaman, MS, Self, S, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, S, Cristillo, AD, Weiss, D, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Wagner, R, Pantaleo, G, & Jacobs, BL. (2018, November 14). Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC. Journal of Virology,.
Bar-On, Y, Gruell, H, Schoofs, T, Pai, JA, Nogueira, L, Butler, AL, Millard, K, Lehmann, C, Suárez, I, Oliveira, TY, Karagounis, T, Cohen, YZ, Wyen, C, Scholten, S, Handl, L, Belblidia, S, Dizon, JP, Vehreschild, JJ, Witmer-Pack, M, Shimeliovich, I, Jain, K, Fiddike, K, Seaton, KE, Yates, NL, Horowitz, J, Gulick, RM, Pfeifer, N, Tomaras, GD, Seaman, MS, Fätkenheuer, G, Caskey, M, Klein, F, & Nussenzweig, MC. (2018, November). Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. Nature Medicine, 24 (11), 1701-1707.
Shen, X, Moodie, Z, McMillan, A, Goodman, D, Yates, N, Spreng, R, Grunenberg, N, Gilbert, P, Phogat, S, Diazgranados, C, Laher, F, Bekker, L-G, Gray, G, Corey, L, McElrath, J, Ferrari, G, & Tomaras, G. (2018, October 1). V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa. HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. MARY ANN LIEBERT, INC.

View All Publications